Research And Markets Research And Markets
0 CHECKOUT

Sri Lanka Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3526542
  • January 2016
  • Region: Sri Lanka
  • 72 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Hemas Holdings
  • MORE

Sales of medicines in Sri Lanka will see reasonable growth ahead. Commercial opportunities are curtailed by the Sri Lanka's under-developed healthcare system and preference for generic drugs.

Multinational drugmaker investments, which could catalyse the sector's growth, will be impaired by the dominant position of state-linked firms and the depreciation of the Sri Lankan rupee.

Headline Expenditure Projections
- Pharmaceuticals: LKR75.1bn (USD575mn) in 2014 to LKR82bn (USD771mn) in 2015. Forecasts remain flat compared with the previous quarter with a downgrade in US dollar terms.

- Healthcare: LKR282.5bn (USD2.2bn) in 2014 to LKR424.0bn (USD2.9bn) in 2015. Forecasts are slightly up compared with the previous quarter with a downgrade in US dollar terms.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Hemas Holdings
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Sri Lanka 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sri Lanka 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2011-2019)

Prescription Drug Market Forecast

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Sri Lanka 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Sri Lanka 2013-2019)

Industry Risk Reward Indices

Asia Pacific Risk/Reward Index

Sri Lanka - Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing And Reimbursement Regimes

Supply Chain

Market Overview

Healthcare Sector

Clinical Trials

Epidemiology

Competitive Landscape

Pharmaceutical Industry
Table: Multinational Market Activity

Pharmaceutical Distribution And Retail

Company Profile

GlaxoSmithKline

Hemas Holdings

State Pharmaceuticals Corporation (SPC)

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Sri Lanka 1990-2025)
Table: Key Population Ratios (Sri Lanka 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Sri Lanka 1990-2025)
Table: Population By Age Group (Sri Lanka 1990-2025)
Table: Population By Age Group % (Sri Lanka 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline
Hemas Holdings
State Pharmaceuticals Corporation (SPC)

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db